Company: HSDTW
Filing Date: 2025-06-27
Form Type: 8-K
Source: 0001558370-25-008942
Chunk: 2

Company: Solana Co
Filing Date: 2025-06-27
Form: 8-K
Item: Item 5.03
Chunk 2
---
 of the Company’s Common Stock as reported on Nasdaq on the last trading day before the Reverse Stock Split becomes effective (on a split-adjusted basis) or (2) rounded up to the next whole share. The number of authorized shares of the Company’s common stock will remain at 150 million, while the number of outstanding shares will be reduced from approximately 33.8 million to approximately 0.7 million.

The Company’s Common Stock will continue to trade on the Nasdaq Capital Market under the symbol “ HSDT.” The new CUSIP number for the Common Stock following the Reverse Stock Split will be 42328V 876.

Equiniti Trust Company, LLC, the Company’s transfer agent, will act as the exchange agent for the Reverse Stock Split.

For more information about the Reverse Stock Split, see the Company’s Definitive Proxy Statement on Schedule 14A (the “ Proxy Statement”), which was filed with the Securities and Exchange Commission and mailed to the Company’s stockholders on or about May 2, 2025, the relevant portions of which are incorporated herein by reference. A copy of the Certificate of Amendment is attached as Exhibit 3.1 hereto and incorporated herein by reference.

  Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit No.      Description                                                                                    
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          3.1      Certificate of Amendment to Certificate of Incorporation of Helius Medical Technologies, Inc.  
          104      Cover Page Interactive Data File (embedded within Inline XBRL document).                       

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                            HELIUS MEDICAL TECHNOLOGIES, INC.                                                        
  Dated: June 27, 2025      By:                                    /s/ Jeffrey S. Mathiesen                          
                                                                   Jeffrey S. Mathiesen                              
                                                                   Chief Financial Officer, Treasurer and Secretary